U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook

U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook published by Frost & Sullivan in January, 2008. This report price starts from US $ 6000.

Introduction

Abstract

This research service covers the U.S. alcohol dependence and abuse pharmaceuticals market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product as follows: Antabuse, Campral, ReVia, and Vivitrol. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

Table of Contents

1 EXECUTIVE SUMMARY

• Executive Summary
  • Introduction

2 TOTAL MARKET

• Research Scope and Methodology
  • Scope and Segmentation
  • Research Methodology
• Disease Overview
  • Introduction
  • Disease Definition
  • Signs and Symptoms
  • Risk Factors
  • Diagnosis
  • Treatment
  • Health Risks of Excessive Alcohol Consumption
  • Disease Statistics
• Patient Outlook
  • Patient Forecasts
• General Market Trends
  • Industry Challenges
  • Market Drivers
  • Market Restraints

3 MARKETED THERAPIES OVERVIEW

• Overview
  • Antabuse
  • Campral
  • ReVia
  • Vivitrol

4 APPENDIX

• Decision Support Databases
  • Road Accident Casualties
  • Liver Cancer Cases
  • Total Consumption of Alcohol
  • Per Capita Consumption of Alcohol
  • Hypertension Prevalence

Related Reports